IMPACT BIOMEDICAL INC. Annual Net Income (Loss) Attributable to Parent in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Impact Biomedical Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2022 to 2023.
  • Impact Biomedical Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$998K, a 17.6% decline year-over-year.
  • Impact Biomedical Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$4.56M.
  • Impact Biomedical Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4.41M, a 39.3% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.41M +$2.85M +39.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 -$7.26M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.